FANGZHOU PHARMACEUTICAL
Fangzhou Pharmaceutical, a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of innovative healthcare solutions. Specialising in a diverse range of products, Fangzhou Pharmaceutical focuses on prescription medications, over-the-counter drugs, and advanced biopharmaceuticals. Their commitment to quality and research has led to the creation of unique formulations that address unmet medical needs. With a strong market position, Fangzhou Pharmaceutical has achieved significant milestones, including numerous certifications and partnerships that enhance its global reach. The company continues to drive advancements in healthcare, making it a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does FANGZHOU PHARMACEUTICAL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FANGZHOU PHARMACEUTICAL's score of 0 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
FANGZHOU PHARMACEUTICAL's reported carbon emissions
FANGZHOU PHARMACEUTICAL, headquartered in CN, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company, indicating a lack of publicly stated commitments towards reducing their carbon footprint or addressing climate change. In the context of the pharmaceutical industry, where sustainability and environmental responsibility are increasingly important, FANGZHOU PHARMACEUTICAL may need to establish clear climate commitments and reduction initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FANGZHOU PHARMACEUTICAL is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
